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The Robert T Wong MD 
Lectureship 
Who could have predicted that on the day that war broke 
out in the Middle East, the annual Lectureship at the UH 
School of Medicine, followed by a gathering of Town & 
Gown for renewed convivial acquaintanceship and refresh-
ments in the pleasant courtyard of the "Pagoda", took place? 
Perhaps I should have said it the other way around: Who 
could have guessed that on the day we listened to an authority 
on the cutting edge of research in the treatment of dread can-
cer affecting the peoples of the world over, an atavistic way of 
resorting to war in order to settle a political issue was any-
thing but dormant in this "advanced", modem, technologically 
sophisticated world of ours? 
Is the human brain so saturated with trivia that the popu-
lace cannot now differentiate the good from the bad? The 
worthwhile from the nonsensical? 
The steeply sloping auditorium of B-103 was peppered 
with a scattering of some 50 people when the last person came 
in. Dean Chris Gulbrandsen MD had approached the podium 
promptly at 4:00 PM, after escorting the speaker Hilary 
Koprowski MD and his wife to their front row seats in front of 
him, our venerable but still young Bob Wong following after. 
This was just a little over an hour after the allied coalition's 
warplanes had taken off from the airfields surrounding Iraq 
and Kuwait, to attack the latter's principal targets at 0400 in 
the dark of night where the Star of Bethlehem once shone. 
Surely all in the sparse audience had been listening to their 
car radios as they drove up to park. What else, in a time of 
instant worldwide CNN news? 
As I got out of my 13 y/o VW Rabbit plastered with anti-
nuclear war stickers, a driver passing by headed for the exit, 
slowed to ask me if I had heard. On my affmnative, he shout-
ed: "Aren't you going to the protest march at the State Capi-
tol?" as he sped off. I wondered if all the would-be audience 
was fleeing as well; or were they glued to their radios instead 
in order to hear the brief words of our country's President due 
to come over the airwaves barely over an hour after the hostil-
ities had started? 
It took an understandably long while for Chris to introduce 
Dr Koprowski; the latter's credentials must have filled several 
pages. In brief, he is the Director of the Wistar Institute and 
Professor of Microbiology at the University of Pennsylvania, 
a world-renowned virologist and pioneer in developing mono-
clonal antibodies for the detection and treatment of cancer. 
It was natural to expect a clone of Einstein to speak to us. 
He was so steeped in the complete knowledge of his particular 
subject - his topic was: Clone to Clinic: Conceptual 
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Approaches to the Immunotherapy of Cancer - that the petty 
niceties of the use of the microphone and the microscopic 
printing of the tables in his slides projected on the huge screen 
escaped his attention. Still, we were able to follow - some-
what blindfolded - the development of his thesis. At least I, 
felt that at my level of a kindergartener, the professor in the 
clouds over my head revealed himself clearly but fleetingly, 
often enough to be followed. My mind would drift at times, 
not inappropriately, to what I had heard on the radio, as an 
outreach observer stationed in Baghdad described the passing 
of an F-16E in the clouds overhead, invisible except for his 
seeing/hearing the trailing screech and thunder; he couldn't 
tell which of his senses registered the impact. 
Never mind the stupid war; let's listen for the prophetic 
knowledge that is opening the door to a cure for cancer ! 
My notes tell me: That Domagk, the inventor of Sulfanil-
amide (1932)*, injected himself with cancerous tissue extracts 
from cadavers in order to determine if an antigen would form 
- to no avail. He didn't die of cancer either; ironically, he 
died of a bacterial infection, the organism resistant to Sulfanil-
amide, no less! 
Forty years of research, in which Koprowski participated, 
with inoculum fmally resulted in 20% of response and devel-
opment of a cancer antigen, working with a virus- the Vac-
cinia Melanoma lysate. Through a complicated method of 
cloning cancer antigens, a monoclonal antibody injected intra-
venously did result in a partial remission in the cancer patient, 
despite the fact that most of the patients were terminal and had 
had all the chemo- and radio-therapy prescribed previously. 
Other data from the occasional patient who recovered from 
cancer revealed that even in the absence of all detectable 
metastases, the bone marrow will often harbor cancer cells. 
The serum of recovered patients may be cytotoxic to cancer 
cells, Koprowski postulated. A single infusion i.v. of the mon-
oclonal anti-anti-antibody (Ab3) results in no cancer cells 
being found in the bone marrow. However, if a patient devel-
ops an antibody on his own, he fares better. The purpose of 
immunotherapy is to stimulate the patient's own formation of 
antibody. 
In the laboratory, using material from viruses, bacteria and 
yeast organisms, the monoclonal antibodies are cultivated and 
treated step by step from Abl to Ab2 to Ab3, Ab3 being the 
same as the Abl that is made by a patient (what I didn't under-
stand, or hear, or grasp, was that something takes 258 days or 
most of a year: is it the in-vitro, or what happens in the patient 
who recovers as a result of developing his own antibodies?). 
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Koprowski's conclusion is that he visualizes the develop-
ment in the not too distant future of vaccines against cancers, 
as a result of the cloning process. Research needs to be done 
- it hasn't been done yet - on patients who have recovered 
from cancer, of which there are more than we realize. Interest-
ingly, many of these antigens are common to several different 
cancers. 
We were enjoying a brief respite from listening to the car 
radio for the latest, over-repetitive, speculative reporting by 
the multimedia. The respite was extended by staying and chat-
ting with colleagues and with Bob. 
We need to tell our readers that the Robert T Wong lecture-
ship was funded originally by Mrs Jean Wong, nee Chow, 
now deceased, but survived by her husband Vernon Wong of 
Bethesda, Maryland, in honor of Bob Wong. 
"The lectureship brings to Hawaii gifted individuals": Drs 
Gallo in 1985, Lansing in 1986, Rosenberg in 1987 and 
Broder in 1989, "who have made major contributions in 
medicine. The intent is to cross-fertilize research ideas and 
What is AMA-ERF? 
The American Medical Association-Education 
and Research Foundation is the major philan-
thropy of organized medicine. It was estab-
lished over 40 years ago by the AMA to 
help assure quality medical education 
and to assist in research in the 
nation's medical schools. As the cost 
of medical education continues to 
increase and sources for funding 
dwindle, support from the medical 
community is vital to ensure that 
future physicians receive the best 
educational and research opportuni-
ties. To date more than $51 million in 
gifts have been distributed to medical 
schools through the Foundation. 
A major factor in the success of AMA-
ERF has been the involvement of the AMA 
Auxiliary, its state and component local auxil-
iaries. Through many different fund-raising efforts, such as 
the holiday sharing card (contributors listed on one greeting 
card mailed to all physicians in the community), dinners, raf-
fles and sales of items, contributions to the Foundation have 
grown substantially. Through the AMA Auxiliary, yearly con-
tributions have averaged over $1 million, and in 1990, reached 
$2 million. 
Contributions to AMA-ERF can benefit the medical school 
of one's choice and can be designated to one of four funds. 
Donations to the Medical School Excellence Fund are unre-
stricted, which allows the medical school to use the money 
where it is needed most. The Medical Students' Assistance 
Fund helps students pay educational costs either through 
loans, grants or scholarships. The Development Fund supports 
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new medical findings for the betterment of people in the 
Pacific Basin and throughout Southeast Asia." 
This is our own Bob Wong's baby; we hope it will contin-
ue because it does contribute to the betterment of our knowl-
edge of medicine here in Hawaii. We also express a hope that 
by its continuance, Hawaii will be adding its very small voice 
for the evolution of peoples who can gradually become more 
civilized, to the extent that wars will be eliminated and peace-
ful pursuits prevail. 
*We learned of a coincidence: in 1942, Bob Wong submit-
ted his thesis toward the requirements for the degree of Master 
of Medical Science for graduate work in ophthalmology at the 
University of Pennsylvania. The title of his thesis was 
Chemotherapy in the Treatment of Gonorrheal Ophthalmia 
subtitled: Relative effectiveness of Sulfanilamide, Sulfapyri-
dine and Sulfathiazole. 
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pilot and experimental health and medical programs. 
The Categorical Fund supports research in specific 
areas. 
Why give to AMA-ERF rather than 
donate directly to a chosen medical school? 
Giving through AMA-ERF maximizes 
individual contributions. The contribu-
tions of many donors combined are sig-
nificant sums that make a difference to 
the medical school. Larger sums of 
money are generated when the medical 
auxiliaries are involved because of pro-
moting fund-raisers, as well as the per-
sonal contact Auxilians make with poten-
tial donors. 
The Auxiliaries also establish personal 
contact with deans of medical schools to ensure 
accountability for the contributions. Greater 
awareness is promoted by the Auxiliaries for the need 
for quality medical education. When physicians and their 
spouses combine their efforts to raise funds for medical 
schools, they demonstrate the support of the entire medical 
community. 
If physicians are already making contributions directly to 
the medical schools of their choice, these can be designated 
"Special Handling" when made through AMA-ERF. 
For information on making contributions through AMA-
ERF, contact AMAA National Committee member or Hawaii 
ERF-Chairman Edith Don (Dr. Andrew Don), 21 Alokele 
Place, Pukalani, Maui, Hawaii 96768, Ph. 572-1107. 
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